Abstract
Lee Schwartzberg, MD, FACP, and Heather Greene, MSN, FNP, AOCNP®, reviewed optimal therapy for patients with hormone receptor–positive, HER2-negative breast cancer, as well as the management of adverse events associated with treatment.
Lee Schwartzberg, MD, FACP, and Heather Greene, MSN, FNP, AOCNP®, reviewed optimal therapy for patients with hormone receptor–positive, HER2-negative breast cancer, as well as the management of adverse events associated with treatment.
Beth Faiman, PhD, MSN, APRN-BC, AOCN®, TCTCN, FAAN, FAPO
November 11, 2026
Katherine Bukolt, DNP, APRN, FNP-C, AOCNP, ROCN, FAPO
November 11, 2026
Ashley E. Allington Drake, MSN, RN, AGACNP-BC, Virginia D. Quinn, MSN, RN, AGACNP-BC, Lauren A. Mason, MSN, RN, AGACNP-BC, Et al.
November 11, 2026
Affiliations:
Specialties:
Areas of Expertise: